Clinical trial
CSP 127-006 A Phase 3 Clinical Trial to Assess Perfusion and Obstruction Identified by Non-Invasive Technology Using PB127 Ultrasound Contrast Agent in Patients With Suspected Obstructive Coronary Arter Disease
NCT00595244 is registered in ClinicalTrials.gov with Point Biomedical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CSP 127-006 A Phase 3 Clinical Trial to Assess Perfusion and Obstruction Identified by Non-Invasive Technology Using PB127 Ultrasound Contrast Agent in Patients With Suspected Obstructive Coronary Arter Disease
- Lead sponsor
- Point Biomedical
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- October 31, 2003
- Enrollment
- 456 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.